• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Uninterrupted warfarin therapy safe for endovascular procedures

byBenjamin Laguna, MDandDylan Wolman
August 7, 2015
in Imaging and Intervention, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Meta-analysis suggests that there is no difference in risk of access site hematoma, bleeding complication, or mortality between interrupted and uninterrupted warfarin therapy for arterial endovascular procedures.

2. For venous procedures, uninterrupted warfarin therapy was associated with a decreased risk of access site hematoma or bleeding complications, and secondary estimates of thrombosis rates were decreased relative to interrupted warfarin therapy as measured by risk of ischemic stroke or myocardial infarction.

Evidence Rating: 2 (Good)

Study Rundown: Patients at risk for thromboembolism, most commonly secondary to atrial fibrillation, on chronic anticoagulation with warfarin commonly discontinue anticoagulation temporarily for endovascular procedures. During this interval off anticoagulation prior to the procedure, patients run a theoretical risk of developing a new thrombosis causing an ischemic stroke, pulmonary embolism, or myocardial infarction if their warfarin is stopped which is weighed against an increased risk of periprocedural bleeding if their anticoagulation is continued. This systematic review and meta-analysis aimed to investigate the risk of bleeding, access site hematoma, and mortality following both arterial and venous endovascular procedures in patients with and without interrupted warfarin therapy.

There was no significant difference between uninterrupted and interrupted warfarin therapy in access site hematoma, bleeding complications, ischemic stroke, or major bleeding when pooling both arterial and venous procedures, and risks of ischemic stroke, major bleeding and access site hematoma actually were reduced among patients undergoing uninterrupted warfarin therapy prior to venous procedures. A lower risk of thrombotic events was attributed to continued anticoagulant therapy, while the decreased risk of bleeding was attributed to the risk provided by bridging patients wherein overlapping agents may provide supratheraputic anticoagulation. This study suggests that arterial and venous endovascular procedures are safe to perform concurrently with warfarin anticoagulation, and that uninterrupted therapy may in fact be associated with superior patient outcomes when performing venous procedures. This study was limited in that few included studies were high-quality randomized controlled trials, no examination of novel oral anticoagulants were included, and concomitant antiplatelet therapy was not assessed, nor were differences in puncture site or use of bridging therapy between anticoagulants. Future studies should aim at providing prospective controlled data to evaluate safety and efficacy, and expand data to include novel oral anticoagulants, antiplatelet agents and different types of endovascular procedures.

Click to read the study in Journal of Radiology

Relevant reading: Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis

RELATED REPORTS

Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis

Active surveillance strategies to improve rates of inferior vena cava filter retrieval

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

In-Depth [meta-analysis]: A literature search of papers from 1990-2014 was completed. Reports comparing vascular procedures in patients on chronic warfarin anticoagulation were included, with 27 studies and a total of 20 376 patients found. In arterial procedures, there was no difference between interrupted and uninterrupted warfarin therapy in access site hematoma (OR, 0.59; 95% confidence interval [CI]: 0.33, 1.03; p = 0.06), any bleeding complications (OR, 0.56; 95% CI: 0.30, 1.06; p = 0.07), mortality (OR, 1.40; 95% CI: 0.37, 5.25; p = 0.62), intracranial hemorrhage (OR, 0.55; 95% CI: 0.03, 8.91; P = .68), ischemic stroke (OR, 0.85; 95% CI: 0.12, 5.84; p = 0.87), and major bleeding (OR, 0.56; 95% CI: 0.21, 1.51; p = 0.25). For venous procedures, uninterrupted warfarin was associated with lower odds of access site hematoma (OR, 0.70; 95% CI: 0.50, 0.99; p = 0.04), any bleeding complications (OR, 0.61; 95% CI: 0.48, 0.77; p < 0.01), ischemic stroke (OR, 0.21; 95% CI: 0.10, 0.45; p < 0.01), and major bleeding (OR, 0.64; 95% CI: 0.51, 0.80; p < 0.01). For arterial and venous procedures combined, uninterrupted warfarin was associated with lower odds of access site hematoma (OR, 0.68; 95% CI: 0.51, 0.91;p = 0.01), bleeding complications (OR, 0.59; 95% CI: 0.48, 0.74; p < 0.01), ischemic stroke (OR, 0.25; 95% CI: 0.12, 0.50; p < 0.01), and major bleeding (OR, 0.61; 95% CI: 0.49, 0.77; p < 0.01). A random effects model with odds ratios was utilized to analyze acquired data.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anticoagulationhematologywarfarin
Previous Post

Topical intracoital tenofovir gel linked to decreased incidence of herpes simplex virus type 2

Next Post

Spicy food consumption linked to a reduction in mortality

RelatedReports

Endocrinology

Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis

March 24, 2023
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Cardiology

Active surveillance strategies to improve rates of inferior vena cava filter retrieval

March 22, 2023
Study explores effects of daily iron supplementation in 2- to 5-year-olds
Chronic Disease

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

March 15, 2023
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Chronic Disease

Valactogene roxaparvovec for hemophilia A demonstrates factor VIII durability for two years

February 27, 2023
Next Post
Spicy food consumption linked to a reduction in mortality

Spicy food consumption linked to a reduction in mortality

Intraperitoneal chemotherapy may be underutilized in ovarian cancer

Intraperitoneal chemotherapy may be underutilized in ovarian cancer

Head circumference better predicts labor dystocia than weight

Head circumference better predicts labor dystocia than weight

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Abnormal menstruation may be associated with worse cardiometabolic outcomes later in life
  • Past infection with pre-omicron variants of COVID-19 protects against re-infection
  • No difference in complete expulsion of intrauterine device between early and standard interval postpartum placement
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options